| 臺大學術典藏 |
2020-04-10T12:51:00Z |
Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma
|
Ou D.-L.;Lin Y.-Y.;Hsu C.-L.;Lin Y.-Y.;Chen C.-W.;Yu J.-S.;Miaw S.-C.;Hsu P.-N.;Cheng A.-L.;Chiun Hsu; Ou D.-L.; Lin Y.-Y.; Hsu C.-L.; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-07T07:00:53Z |
Increased Risk of Acute Cholecystitis in Patients With Spinal Cord Injury: A Nationwide Population-Based Cohort Study
|
Hsu C.-L.; Wang M.-T.; Ho Y.-C.; SHIN-LIANG PAN; Hsu C.-L.;Wang M.-T.;Ho Y.-C.;Shin-Liang Pan |
| 臺大學術典藏 |
2020-04-07T07:00:53Z |
Spinal cord injury and Alzheimer's disease risk: A population-based, retrospective cohort study article
|
SHIN-LIANG PAN; Hsu C.-L.; Ho Y.-C.; Yeh T.-S.;Ho Y.-C.;Hsu C.-L.;Shin-Liang Pan; Yeh T.-S. |
| 臺大學術典藏 |
2020-03-31T08:54:40Z |
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
|
Yang P.-C.; LI-NA LEE; Hsueh P.-R.; Yu C.-J.; Hsu C.-L.; Tsai T.-H.; Wang J.-T.; Wang J.-Y. |
| 臺大學術典藏 |
2020-03-31T08:54:37Z |
Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns
|
LI-NA LEE; Yu C.-J.; Shu C.-C.; Lee C.-H.; Hsu C.-L.; Wang J.-T.; Wang J.-Y. |
| 臺大學術典藏 |
2020-03-31T08:54:34Z |
Apoptosis-associated biomarkers in tuberculosis: Promising for diagnosis and prognosis prediction
|
Yang P.-C.; LI-NA LEE; Yu C.-J.; Shu C.-C.; Wu M.-F.; Hsu C.-L.; Huang C.-T.; Wang J.-Y.; Hsieh S.-L. |
| 臺大學術典藏 |
2020-03-31T08:54:31Z |
Tuberculosis mortality: Patient characteristics and causes
|
LI-NA LEE; Cheng W.-C.; Chen J.-M.; Hsu C.-L.; Wang J.-Y.; Kuo Y.-W.; Lin C.-J.; Lin C.-H. |
| 臺大學術典藏 |
2020-03-31T08:54:29Z |
Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment
|
Wang J.Y.; Tsai C.H.; Lee Y.L.; LI-NA LEE; Hsu C.L.; Chang H.C.; Chen J.M.; Hsu C.A.; Yu C.J.; Yang P.C. |
| 臺大學術典藏 |
2020-03-31T08:54:29Z |
Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study
|
LI-NA LEE; Wang J.-T.; Yu C.-J.; Yang F.-J.; Wu V.-C.; Wang J.-Y.; Lee C.-Y.; Shu C.-C.; Hsu C.-L. |
| 臺大學術典藏 |
2020-03-31T08:54:28Z |
Risk of tuberculosis among patients on dialysis
|
Yu C.-J.; LI-NA LEE; Chen J.-S.; Wang J.-Y.; Yang F.-J.; Lin H.-H.; Wu V.-C.; Liou H.-H.; Lee C.-Y.; Wei Y.-F.; Hsu C.-L.; Shu C.-C. |
| 臺大學術典藏 |
2020-03-31T08:54:27Z |
The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease
|
Lin C.-H.; Shu C.-C.; Hsu C.-L.; Cheng S.-L.; Wang J.-Y.; Yu C.-J.; LI-NA LEE |
| 臺大學術典藏 |
2020-03-31T08:54:27Z |
Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population
|
LI-NA LEE; Yu C.-J.; Yang F.-J.; Wang J.-Y.; Wu V.-C.; Lee C.-Y.; Hsu C.-L.; Shu C.-C. |
| 臺大學術典藏 |
2020-03-30T08:50:44Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; Lin Y.-T.;Jin-Shing Chen;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; JIN-SHING CHEN; Liao W.-Y. |
| 臺大學術典藏 |
2020-03-27T05:30:03Z |
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
|
Yang P.-C.; Lee L.-N.; PO-REN HSUEH; Yu C.-J.; Hsu C.-L.; Wang J.-T.; Tsai T.-H.; Wang J.-Y.; Yang P.-C.;Lee L.-N.;PO-REN HSUEH;Yu C.-J.;Hsu C.-L.;Tsai T.-H.;Wang J.-T.;Wang J.-Y. |
| 臺大學術典藏 |
2020-03-23T05:53:56Z |
Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression
|
Juan H.-F.; Huang H.-C.; Hsu W.-M.; CHIUNG-NIEN CHEN; Chen S.-F.; Yang T.-S.; Huang C.-T.; Hsu C.-L.; Hou C.-L.; Liu Y.-L.; Cheung C.H.Y.; Hsieh C.-H.; Hsieh C.-H.;Cheung C.H.Y.;Liu Y.-L.;Hou C.-L.;Hsu C.-L.;Huang C.-T.;Yang T.-S.;Chen S.-F.;Chiung-Nien Chen;Hsu W.-M.;Huang H.-C.;Juan H.-F. |
| 臺大學術典藏 |
2020-03-07T06:56:14Z |
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
|
Hsu C.-L.;Chen K.-Y.;Kuo S.-W.;Yih-Leong Chang; Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:11Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:09Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T08:24:45Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Yung-Ming Jeng;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; YUNG-MING JENG; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
|
Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-06T05:26:02Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:00Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-05T08:38:05Z |
Impaired exercise capacity in diabetic patients after coronary bypass surgery: Effects of diastolic and endothelial function
|
Wu Y.-W.;Hsu C.-L.;Shoei-Shen Wang;Tsai M.-W.;Chu S.-H.;Chen Y.-S.;Yang W.-S.;Wu Y.-T.; Wu Y.-W.; Hsu C.-L.; SHOEI-SHEN WANG; Tsai M.-W.; Chu S.-H.; Chen Y.-S.; Yang W.-S.; Wu Y.-T. |
| 臺大學術典藏 |
2020-03-05T03:20:09Z |
Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma
|
Sahu D.; Hsu C.-L.; Lin C.-C.; Yang T.-W.; WEN-MING HSU; Ho S.-Y.; Juan H.-F.; Huang H.-C. |
| 臺大學術典藏 |
2020-03-05T03:20:09Z |
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
|
Hsu C.-L.; Chang H.-Y.; Chang J.-Y.; WEN-MING HSU; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-05T03:20:03Z |
Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy
|
Cheung C.H.Y.;Hsu C.-L.;Tsuei C.-Y.;Kuo T.-T.;Huang C.-T.;Wen-Ming Hsu;Chung Y.-H.;Wu H.-Y.;Hsu C.-C.;Huang H.-C.;Juan H.-F.; Cheung C.H.Y.; Hsu C.-L.; Tsuei C.-Y.; Kuo T.-T.; Huang C.-T.; WEN-MING HSU; Chung Y.-H.; Wu H.-Y.; Hsu C.-C.; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-05T03:20:03Z |
Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression
|
Hsieh C.-H.; Cheung C.H.Y.; Liu Y.-L.; Hou C.-L.; Hsu C.-L.; Huang C.-T.; Yang T.-S.; Chen S.-F.; Chen C.-N.; WEN-MING HSU; Huang H.-C.; Juan H.-F. |
| 臺大學術典藏 |
2020-03-02T06:05:22Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:21Z |
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
|
Juan H.-F.; Hsu C.-L.; MIN-CHUAN HUANG; Lai I.-R.; Hung K.-Y.; Liu S.-Y.; Shun C.-T. |
| 臺大學術典藏 |
2020-03-02T06:05:19Z |
GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
|
Lin T.-C.; Chen S.-T.; MIN-CHUAN HUANG; Huang J.; Hsu C.-L.; Juan H.-F.; Lin H.-H.; Chen C.-H. |
| 臺大學術典藏 |
2020-03-02T06:05:18Z |
GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
|
Lin M.-C.; Lin J.-J.; Hsu C.-L.; Juan H.-F.; Lou P.-J.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T06:05:15Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Hung J.-S.;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Min-Chuan Huang; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; Hsu C.-L.; Juan H.-F.; Lee P.-H.; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-03-02T03:10:45Z |
Analysis of experience-regulated transcriptome and imprintome during critical periods of mouse visual system development reveals spatiotemporal dynamics
|
Hsu C.-L.; Chou C.-H.; Huang S.-C.; Lin C.-Y.; Lin M.-Y.; Tung C.-C.; Lai I.P.; Zou Y.-F.; Youngson N.A.; Lin S.-P.; Yang C.-H.; Chen S.-K.; SUSAN SHUR-FEN GAU; Huang H.-S. |
| 臺大學術典藏 |
2020-02-25T06:21:29Z |
Carrier localization in InN epilayers grown on Si substrates
|
Shu, G. W.; Lo, M. H.; Yang, M. D.; Hsu, C. L.; Shen, J. L.; Lan, S. M.; MIN-HUI LO |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-C.; Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; JI-SHIANG HUNG; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M. |
| 臺大學術典藏 |
2020-02-25T05:15:24Z |
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
|
Lee P.-C.;Chen S.-T.;Kuo T.-C.;Lin T.-C.;Lin M.-C.;Huang J.;Ji-Shiang Hung;Hsu C.-L.;Juan H.-F.;Lee P.-H.;Huang M.-C.; Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; JI-SHIANG HUNG; Hsu C.-L.; Juan H.-F.; Lee P.-H.; Huang M.-C. |
| 臺大學術典藏 |
2020-02-24T01:33:40Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Jeng Y.-M.;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Rey-Heng Hu;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; REY-HENG HU; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-20T02:57:00Z |
Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients
|
Yeh J.-H.; Huang C.-T.; Liu C.-H.; Ruan S.-Y.; Tsai Y.-J.; Chien Y.-C.; CHING-YAO YANG; Huang C.-K.; Hsu C.-L.; Kuo L.-C.; Lee P.-L.; Ku S.-C.; Kuo P.-H.; Yu C.-J.; HINT Study Group |
| 臺大學術典藏 |
2020-02-20T02:56:56Z |
Effects of acute critical illnesses on the performance of interferon-gamma release assay
|
Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; Kuo P.-H.; Ku S.-C.; Lee P.-L.; Kuo L.-C.; Hsu C.-L.; Huang C.-K.; CHING-YAO YANG; Chien Y.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-02-20T02:56:53Z |
3′UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma
|
Hua K.-T.; Liu Y.-F.; Hsu C.-L.; Cheng T.-Y.; CHING-YAO YANG; Chang J.-S.; Lee W.-J.; Hsiao M.; Juan H.-F.; Chien M.-H.; Yang S.-F. |
| 臺大學術典藏 |
2020-02-19T09:33:37Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Jeng Y.-M.;Ming-Chih Ho;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; MING-CHIH HO; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-17T08:50:51Z |
GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
|
Lin T.-C; Chen S.-T; Huang M.-C; Huang J; Hsu C.-L; Juan H.-F; HO-HSIUNG LIN; Chen C.-H. |
| 臺大學術典藏 |
2020-02-13T07:58:38Z |
GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
|
MEI-CHUN LIN; Lin J.-J.; Hsu C.-L.; Juan H.-F.; Lou P.-J.; Huang M.-C. |
| 臺大學術典藏 |
2020-02-11T07:58:37Z |
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
|
Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; YAO-MING WU; Huang M.-C. |
| 臺大學術典藏 |
2020-02-11T03:53:48Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.;Hsu C.-L.;Jeng Y.-M.;Ho M.-C.;Cheng-Maw Ho;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; Ho M.-C.; CHENG-MAW HO; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-06T10:53:41Z |
Specific Binding of Single-stranded Telomeric DNA by Cdc13p of Saccharomyces cerevisiae
|
Hsu C.-L.; Shih J.-W.; JING-JER LIN; Lin Y.-C.;Hsu C.-L.;Shih J.-W.;Jing-Jer Lin; Lin Y.-C. |
| 臺大學術典藏 |
2020-02-06T10:53:41Z |
Renaturation and stabilization of the telomere-binding activity of Saccharomyces Cdc13(451-693)p by L-arginine
|
Lin Y.-C.; Shih J.-W.; Hsu C.-L.; JING-JER LIN; Lin Y.-C.;Shih J.-W.;Hsu C.-L.;Jing-Jer Lin |
| 臺大學術典藏 |
2020-02-06T10:53:40Z |
Exposure of single-stranded telomeric DNA causes G2/M cell cycle arrest in Saccharomyces cerevisiae
|
Pang T.-L.;Wang C.-Y.;Hsu C.-L.;Chen M.-Y.;Jing-Jer Lin; Pang T.-L.; Wang C.-Y.; Hsu C.-L.; Chen M.-Y.; JING-JER LIN |
